GLIMIMED PG2
Glimimed, Metformin & Pioglitazone Tablets
Composition (Each tablet contains):
Glimimed (Glimepiride): 2 mg
Metformin Hydrochloride (SR/IR as applicable): 500 mg
Pioglitazone: 15 mg
Therapeutic Class: Oral Antidiabetic Combination
Glimepiride 2 mg + Metformin 500 mg + Pioglitazone 15 mg Tablet (GLIMIMED 2) is prescribed for the control of type 2 diabetes in adults when diet, exercise, and monotherapy are inadequate.
Glimepiride 2 mg + Metformin 500 mg + Pioglitazone 15 mg Tablet (GLIMIMED 2) is prescribed for the control of type 2 diabetes in adults when diet, exercise, and monotherapy are inadequate. Glimepiride increases insulin secretion, Metformin decreases liver glucose output, and Pioglitazone enhances muscle and fat tissue insulin sensitivity. The combination provides optimal blood glucose control.
Glimepiride 2 mg + Metformin 500 mg + Pioglitazone 15 mg Tablet (GLIMIMED 2) is prescribed for the control of type 2 diabetes in adults when diet, exercise, and monotherapy are inadequate. Glimepiride increases insulin secretion, Metformin decreases liver glucose output, and Pioglitazone enhances muscle and fat tissue insulin sensitivity. The combination provides optimal blood glucose control.
FAQ
Q: May I use this medicine with insulin?
A: It is generally not used with insulin except on the advice of your physician under close observation.
Q: How often a day do I need to take this tablet?
A: Generally once or twice a day with meals, as directed by your physician.
Q: What to do in case of a missed dose?
A: Take as soon as you remember but skip if near the time for the next dose. Do not double.
Q: Is frequent blood sugar monitoring necessary with this tablet?
A: Yes, regular monitoring ensures good sugar control and avoids hypoglycemia.
FAQ
Apply for PCD Franchise – Not for Job Queries
Apply for PCD Franchise – Not for Job Queries
